Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

Published Oct 19, 2020

Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

People with relapsed or treatment-resistant classic Hodgkin Lymphoma now have FDA approval to use Keytruda. The immunotherapy treatment is proven to extend life.

NOW
PLAYING
Remembering America's Father Figure Robert Reed aka Mike Brady from 'The Brady Bunch' Who Died From Cancer
NOW
PLAYING
NFL Coach Ron Rivera on His Skin Cancer Treatment Path
NOW
PLAYING
Can You Afford the High Cost of CAR T-Cell Therapy?
NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
Makeup Mogul Kylie Jenner Helps Teens with Cancer in Honor of Close Pal Harry Hudson, a Stage 3 Hodgkin Lymphoma Survivor
NOW
PLAYING
'Country Ever After' Star Criscilla Anderson, 40, Says She Could Be on Chemotherapy the 'Rest of My Life' for Advanced Colon Cancer

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.